Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey

Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey

Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB97-AB97
Hauptverfasser: Trudo, Frank J., MD, MBA, Davis, Jill R., MS, Small, Mark, Siddall, James, Pike, James
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page AB97
container_issue 2
container_start_page AB97
container_title Journal of allergy and clinical immunology
container_volume 139
creator Trudo, Frank J., MD, MBA
Davis, Jill R., MS
Small, Mark
Siddall, James
Pike, James
description Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).
doi_str_mv 10.1016/j.jaci.2016.12.317
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1867947442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674916318358</els_id><sourcerecordid>4313579691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2237-e2621c494fd61b2f710eec00078973fc38bbe79d8c35e9084dad7e9fdc9bc58b3</originalsourceid><addsrcrecordid>eNp9kV2L1DAUhosoOK7-Aa8CXnc2H50mERG6o-MujCjWxcuQJqczqW0zm7Qr8-9NGUHwwqvzwXnPeXlOlr0meE0wKa-7daeNW9OUrwldM8KfZCuCJc9LQTdPsxXGkuQlL-Tz7EWMHU41E3KV_arPw2nyg56cQTdzsDAi36IqTsdBo6-pDeMUUWWPEFKGJo8-g3XzkCMf0K07HPMPPuoDoLttfb2vbqq3aOdG68ZDRLvgB6TRfY2-ge7RDx96i-o5PML5Zfas1X2EV3_iVXa_-_h9e5vvv3y621b73FDKeA60pMQUsmhtSRracoIBTHLPheSsNUw0DXBphWEbkFgUVlsOsrVGNmYjGnaVvbnsPQX_MEOcVOfnMKaTioiSy4IXBU1T9DJlgo8xQKtOwQ06nBXBagGsOrUAVgtgRahKgJPo3UUEyf-jg6CiSbRMwhPATMp693_5-3_kpnejM7r_CWeIf22qSBVW9fLB5YGkZESwjWC_AeF8l64</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867947442</pqid></control><display><type>article</type><title>Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Trudo, Frank J., MD, MBA ; Davis, Jill R., MS ; Small, Mark ; Siddall, James ; Pike, James</creator><creatorcontrib>Trudo, Frank J., MD, MBA ; Davis, Jill R., MS ; Small, Mark ; Siddall, James ; Pike, James</creatorcontrib><description>Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2016.12.317</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Allergy and Immunology ; Asthma</subject><ispartof>Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB97-AB97</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Feb 01, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674916318358$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Trudo, Frank J., MD, MBA</creatorcontrib><creatorcontrib>Davis, Jill R., MS</creatorcontrib><creatorcontrib>Small, Mark</creatorcontrib><creatorcontrib>Siddall, James</creatorcontrib><creatorcontrib>Pike, James</creatorcontrib><title>Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey</title><title>Journal of allergy and clinical immunology</title><description>Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).</description><subject>Allergy and Immunology</subject><subject>Asthma</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kV2L1DAUhosoOK7-Aa8CXnc2H50mERG6o-MujCjWxcuQJqczqW0zm7Qr8-9NGUHwwqvzwXnPeXlOlr0meE0wKa-7daeNW9OUrwldM8KfZCuCJc9LQTdPsxXGkuQlL-Tz7EWMHU41E3KV_arPw2nyg56cQTdzsDAi36IqTsdBo6-pDeMUUWWPEFKGJo8-g3XzkCMf0K07HPMPPuoDoLttfb2vbqq3aOdG68ZDRLvgB6TRfY2-ge7RDx96i-o5PML5Zfas1X2EV3_iVXa_-_h9e5vvv3y621b73FDKeA60pMQUsmhtSRracoIBTHLPheSsNUw0DXBphWEbkFgUVlsOsrVGNmYjGnaVvbnsPQX_MEOcVOfnMKaTioiSy4IXBU1T9DJlgo8xQKtOwQ06nBXBagGsOrUAVgtgRahKgJPo3UUEyf-jg6CiSbRMwhPATMp693_5-3_kpnejM7r_CWeIf22qSBVW9fLB5YGkZESwjWC_AeF8l64</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Trudo, Frank J., MD, MBA</creator><creator>Davis, Jill R., MS</creator><creator>Small, Mark</creator><creator>Siddall, James</creator><creator>Pike, James</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20170201</creationdate><title>Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey</title><author>Trudo, Frank J., MD, MBA ; Davis, Jill R., MS ; Small, Mark ; Siddall, James ; Pike, James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2237-e2621c494fd61b2f710eec00078973fc38bbe79d8c35e9084dad7e9fdc9bc58b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Allergy and Immunology</topic><topic>Asthma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trudo, Frank J., MD, MBA</creatorcontrib><creatorcontrib>Davis, Jill R., MS</creatorcontrib><creatorcontrib>Small, Mark</creatorcontrib><creatorcontrib>Siddall, James</creatorcontrib><creatorcontrib>Pike, James</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trudo, Frank J., MD, MBA</au><au>Davis, Jill R., MS</au><au>Small, Mark</au><au>Siddall, James</au><au>Pike, James</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>139</volume><issue>2</issue><spage>AB97</spage><epage>AB97</epage><pages>AB97-AB97</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Methods Cross-sectional data from 3 US Adelphi asthma surveys, conducted during 2013- 2016, were analysed in diagnosed asthma patients, prescribed medium- or high-dosage ICS/LABA treatment with self-reported medium to high adherence (Morisky Medication Adherence Scale).</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2016.12.317</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB97-AB97
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1867947442
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Allergy and Immunology
Asthma
title Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A43%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Symptomatic%20Burden%20of%20Asthma%20Patients%20Adherent%20to%20Medium-%20or%20High-Dosage%20ICS/LABA:%20Findings%20From%20a%20US%20Real%20World%20Survey&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Trudo,%20Frank%20J.,%20MD,%20MBA&rft.date=2017-02-01&rft.volume=139&rft.issue=2&rft.spage=AB97&rft.epage=AB97&rft.pages=AB97-AB97&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2016.12.317&rft_dat=%3Cproquest_cross%3E4313579691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1867947442&rft_id=info:pmid/&rft_els_id=S0091674916318358&rfr_iscdi=true